ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.58043/rphrc.4 |
Resumo: | Introduction: Heart Failure is a cardiovascular syndrome resulting from a structural and/or functional anomaly of the cardiac muscle, resulting in reduced cardiac output and elevated intracardiac pressures. Adherence to antihypertensive therapy has a major influence on the outcomes of heart failure, not limited only to the treatment of high blood pressure, but also the regulation of the hydro-electrolytic balance and the reduction of cardiac workload. To achieve better outcomes, the identification of the main reasons underlying the low adherence rates to optimized HF medical therapy is necessary. Objective: This study aimed to evaluate heart failure patients’ adherence to antihypertensive therapy and associated causes for non-adherence. Methods: Cross-sectional study conducted in the cardiology department of Coimbra ́s Tertiary Hospital. Between June 2019 and November 2019 all consecutive adult heart failure patients attending to the outpatient HF outpatient clinic, with a prescription of, at least, one antihypertensive agent, were invited to participate. This study was approved by the local Ethics Commission (CE 008-19). Socio-demographic and patient-related data were collected and the short version of Maastricht Utrecht Adherence in Hypertension, MUAH-16, was applied. Results: A total of 125 patients were enrolled in the study, 72.8% males, with a mean age of 65.7 ± 1.7 years [62 with a blood pressure tendentially high or normal (HT) and 63 with low blood pressure (HoT)]. The mean score of MUAH-16 on the total sample was 93.4 ± 7. 5 (in a maximum of 112 points). Considering the mean scores of MUAH-16 subscales, being 28 points the maximum scoring, the results obtained were: positive attitude toward health care and medication: 25.9 ± 2.6; lack of discipline: 25.4 ± 3.5; aversion toward medication: 19.7 ± 4.7; active coping with health problems: 22.1 ± 3.3. Sub-group analysis shows no statistically significant differences between HT and HoT patients. Conclusion: The studied population showed satisfactory levels of adherence to antihypertensive therapy, even so, improvements can be obtained if specific strategies to decrease aversion toward medication and to improve active coping with health problems are developed. |
id |
RCAP_5387fad37ccb8cf360c4376c10aa4a5b |
---|---|
oai_identifier_str |
oai:ojs.revistahipertensao.pt:article/4 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTREADESÃO À MEDICAÇÃO ANTIHIPERTENSORA EM DOENTES COM INSUFICIÊNCIA CARDÍACA SEGUIDOS NUM HOSPITAL CENTRAL TERCIÁRIOInsuficiência CardíacaAdesão à terapêuticaMedicação antihipertensoraQuestionáriosMUAH-16Heart FailureTreatment Adherence and ComplianceQuestionnairesAntihypertensive AgentsMUAH-16Introduction: Heart Failure is a cardiovascular syndrome resulting from a structural and/or functional anomaly of the cardiac muscle, resulting in reduced cardiac output and elevated intracardiac pressures. Adherence to antihypertensive therapy has a major influence on the outcomes of heart failure, not limited only to the treatment of high blood pressure, but also the regulation of the hydro-electrolytic balance and the reduction of cardiac workload. To achieve better outcomes, the identification of the main reasons underlying the low adherence rates to optimized HF medical therapy is necessary. Objective: This study aimed to evaluate heart failure patients’ adherence to antihypertensive therapy and associated causes for non-adherence. Methods: Cross-sectional study conducted in the cardiology department of Coimbra ́s Tertiary Hospital. Between June 2019 and November 2019 all consecutive adult heart failure patients attending to the outpatient HF outpatient clinic, with a prescription of, at least, one antihypertensive agent, were invited to participate. This study was approved by the local Ethics Commission (CE 008-19). Socio-demographic and patient-related data were collected and the short version of Maastricht Utrecht Adherence in Hypertension, MUAH-16, was applied. Results: A total of 125 patients were enrolled in the study, 72.8% males, with a mean age of 65.7 ± 1.7 years [62 with a blood pressure tendentially high or normal (HT) and 63 with low blood pressure (HoT)]. The mean score of MUAH-16 on the total sample was 93.4 ± 7. 5 (in a maximum of 112 points). Considering the mean scores of MUAH-16 subscales, being 28 points the maximum scoring, the results obtained were: positive attitude toward health care and medication: 25.9 ± 2.6; lack of discipline: 25.4 ± 3.5; aversion toward medication: 19.7 ± 4.7; active coping with health problems: 22.1 ± 3.3. Sub-group analysis shows no statistically significant differences between HT and HoT patients. Conclusion: The studied population showed satisfactory levels of adherence to antihypertensive therapy, even so, improvements can be obtained if specific strategies to decrease aversion toward medication and to improve active coping with health problems are developed.Introdução: A insuficiência cardíaca é uma síndrome do foro cardiovascular resultante de uma anomalia estrutural e/ou funcional do músculo cardíaco, originando a redução do débito cardíaco e elevação das pressões intracardíacas. A adesão à terapêutica antihipertensora tem uma grande influência no decurso da doença, não se limitando apenas ao tratamento da hipertensão, mas também à regulação do equilíbrio hidroeletrolítico e à redução da sobrecarga cardíaca. A identificação dos principais motivos subjacentes às baixas taxas de adesão à terapêutica farmacológica em doentes diagnosticados com insuficiência cardíaca permitirá uma otimização destes mesmos valores. Objetivo: Este estudo teve como objetivo avaliar a adesão à terapêutica antihipertensora em doentes com insuficiência cardíaca e as causas associadas à não adesão.Materiais e Métodos: Estudo observacional transversal realizado no Serviço de Cardiologia do Centro Hospitalar e Universitário da Universidade de Coimbra, entre junho de 2019 e novembro de 2019, com inclusão de doentes com diagnóstico de Insuficiência Cardíaca, e prescrição de pelo menos um medicamento antihipertensor. Os dados relacionados com a informação sociodemográfica e estado de saúde do participante foram recolhidos e a versão curta do questionário Maastricht Utrecht Adherence in Hypertension, MUAH-16, foi aplicada. Resultados: Foram incluídos no estudo 125 doentes, 72,8% do sexo masculino, com idade mediana de 65,7 ± 1,7 anos [62 com pressão arterial tendencionalmente alta a normal (HT) e 63 com pressão arterial tendencionalmente baixa (HoT)]. A pontuação mediana do MUAH-16 na amostra total foi de 93,4 ± 7,5 (num máximo de 112 pontos). Considerando as pontuações medianas das subescalas MUAH-16, sendo 28 pontos a pontuação máxima, os resultados obtidos foram: atitudes positivas em relação aos medicamentos e cuidados de saúde: 25,9 ± 2,6; falta de disciplina: 25,4 ± 3,5; aversão à medicação: 19,7 ± 4,7; atitudes proactivas em relação aos problemas de saúde: 22,1 ± 3,3. A análise de subgrupos demonstra que não existem diferenças estatisticamente significativas entre os pacientes com HT e HoT. Conclusão: A população em estudo apresentou níveis satisfatórios de adesão à terapia antihipertensora. Apesar deste facto, podem ser obtidas melhorias se forem desenvolvidas estratégias específicas para diminuir a aversão à medicação e melhorar as atitudes proactivas em relação aos problemas de saúde.Revista Portuguesa de Hipertensão e Risco Cardiovascular2022-05-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.58043/rphrc.4https://doi.org/10.58043/rphrc.4Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 87 (2022): Janeiro - Fevereiro; 14-191646-8287reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revistahipertensao.pt/index.php/rh/article/view/4https://revistahipertensao.pt/index.php/rh/article/view/4/3Pedroso, DiogoNorberto, AnaCabral, AnaLavrador, MartaCastel-Branco, MargaridaFernandez-Llimos, FernandoGonçalves, LinoVitória Figueiredo, Isabelinfo:eu-repo/semantics/openAccess2024-02-03T07:36:10Zoai:ojs.revistahipertensao.pt:article/4Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:05:06.907730Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE ADESÃO À MEDICAÇÃO ANTIHIPERTENSORA EM DOENTES COM INSUFICIÊNCIA CARDÍACA SEGUIDOS NUM HOSPITAL CENTRAL TERCIÁRIO |
title |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
spellingShingle |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE Pedroso, Diogo Insuficiência Cardíaca Adesão à terapêutica Medicação antihipertensora Questionários MUAH-16 Heart Failure Treatment Adherence and Compliance Questionnaires Antihypertensive Agents MUAH-16 |
title_short |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
title_full |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
title_fullStr |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
title_full_unstemmed |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
title_sort |
ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN HEART FAILURE PATIENTS FOLLOWED IN A TERTIARY HOSPITAL CENTRE |
author |
Pedroso, Diogo |
author_facet |
Pedroso, Diogo Norberto, Ana Cabral, Ana Lavrador, Marta Castel-Branco, Margarida Fernandez-Llimos, Fernando Gonçalves, Lino Vitória Figueiredo, Isabel |
author_role |
author |
author2 |
Norberto, Ana Cabral, Ana Lavrador, Marta Castel-Branco, Margarida Fernandez-Llimos, Fernando Gonçalves, Lino Vitória Figueiredo, Isabel |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Pedroso, Diogo Norberto, Ana Cabral, Ana Lavrador, Marta Castel-Branco, Margarida Fernandez-Llimos, Fernando Gonçalves, Lino Vitória Figueiredo, Isabel |
dc.subject.por.fl_str_mv |
Insuficiência Cardíaca Adesão à terapêutica Medicação antihipertensora Questionários MUAH-16 Heart Failure Treatment Adherence and Compliance Questionnaires Antihypertensive Agents MUAH-16 |
topic |
Insuficiência Cardíaca Adesão à terapêutica Medicação antihipertensora Questionários MUAH-16 Heart Failure Treatment Adherence and Compliance Questionnaires Antihypertensive Agents MUAH-16 |
description |
Introduction: Heart Failure is a cardiovascular syndrome resulting from a structural and/or functional anomaly of the cardiac muscle, resulting in reduced cardiac output and elevated intracardiac pressures. Adherence to antihypertensive therapy has a major influence on the outcomes of heart failure, not limited only to the treatment of high blood pressure, but also the regulation of the hydro-electrolytic balance and the reduction of cardiac workload. To achieve better outcomes, the identification of the main reasons underlying the low adherence rates to optimized HF medical therapy is necessary. Objective: This study aimed to evaluate heart failure patients’ adherence to antihypertensive therapy and associated causes for non-adherence. Methods: Cross-sectional study conducted in the cardiology department of Coimbra ́s Tertiary Hospital. Between June 2019 and November 2019 all consecutive adult heart failure patients attending to the outpatient HF outpatient clinic, with a prescription of, at least, one antihypertensive agent, were invited to participate. This study was approved by the local Ethics Commission (CE 008-19). Socio-demographic and patient-related data were collected and the short version of Maastricht Utrecht Adherence in Hypertension, MUAH-16, was applied. Results: A total of 125 patients were enrolled in the study, 72.8% males, with a mean age of 65.7 ± 1.7 years [62 with a blood pressure tendentially high or normal (HT) and 63 with low blood pressure (HoT)]. The mean score of MUAH-16 on the total sample was 93.4 ± 7. 5 (in a maximum of 112 points). Considering the mean scores of MUAH-16 subscales, being 28 points the maximum scoring, the results obtained were: positive attitude toward health care and medication: 25.9 ± 2.6; lack of discipline: 25.4 ± 3.5; aversion toward medication: 19.7 ± 4.7; active coping with health problems: 22.1 ± 3.3. Sub-group analysis shows no statistically significant differences between HT and HoT patients. Conclusion: The studied population showed satisfactory levels of adherence to antihypertensive therapy, even so, improvements can be obtained if specific strategies to decrease aversion toward medication and to improve active coping with health problems are developed. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-05-10 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.58043/rphrc.4 https://doi.org/10.58043/rphrc.4 |
url |
https://doi.org/10.58043/rphrc.4 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revistahipertensao.pt/index.php/rh/article/view/4 https://revistahipertensao.pt/index.php/rh/article/view/4/3 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular |
publisher.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular |
dc.source.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 87 (2022): Janeiro - Fevereiro; 14-19 1646-8287 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130513320968192 |